Your browser doesn't support javascript.
loading
Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
Saluja, Tarun; Palkar, Sonali; Misra, Puneet; Gupta, Madhu; Venugopal, Potula; Sood, Ashwani Kumar; Dhati, Ravi Mandyam; Shetty, Avinash; Dhaded, Sangappa Malappa; Agarkhedkar, Sharad; Choudhury, Amlan; Kumar, Ramesh; Balasubramanian, Sundaram; Babji, Sudhir; Adhikary, Lopa; Dupuy, Martin; Chadha, Sangeet Mohan; Desai, Forum; Kukian, Darshna; Patnaik, Badri Narayan; Dhingra, Mandeep Singh.
Afiliação
  • Saluja T; Shantha Biotechnics Pvt. Ltd., Hyderabad, India. Electronic address: Tarun.Saluja@sanofi.com.
  • Palkar S; Bharati Vidyapeeth Deemed University Medical College, Pune, India.
  • Misra P; All India Institute of Medical Sciences, New Delhi, India.
  • Gupta M; Post Graduate Institute of Medical Education & Research, Chandigarh, India.
  • Venugopal P; King George Hospital, Visakhapatnam, India.
  • Sood AK; Indira Gandhi Medical College, Shimla, India.
  • Dhati RM; JSS University, Mysore, India.
  • Shetty A; Dr. TMA Pai Rotary Hospital, Karkala, India.
  • Dhaded SM; J N Medical College, Belgaum, India.
  • Agarkhedkar S; Padmashree Dr. D. Y. Patil Medical College & Research Center, Pune, India.
  • Choudhury A; KPC Medical College & Hospital, Kolkata, India.
  • Kumar R; Pt. Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, India.
  • Balasubramanian S; Kanchi Kamakoti Child Trust Hospital & The Child Trust Medical Research Foundation, Chennai, India.
  • Babji S; Christian Medical College, Vellore, Tamil Nadu, India.
  • Adhikary L; Shantha Biotechnics Pvt. Ltd., Hyderabad, India.
  • Dupuy M; Sanofi Pasteur, Marcy-l'Étoile, France.
  • Chadha SM; Shantha Biotechnics Pvt. Ltd., Hyderabad, India.
  • Desai F; Shantha Biotechnics Pvt. Ltd., Hyderabad, India.
  • Kukian D; Shantha Biotechnics Pvt. Ltd., Hyderabad, India.
  • Patnaik BN; Shantha Biotechnics Pvt. Ltd., Hyderabad, India.
  • Dhingra MS; Sanofi Pasteur, Swiftwater, USA.
Vaccine ; 35(28): 3575-3581, 2017 06 16.
Article em En | MEDLINE | ID: mdl-28536027
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Infecções por Rotavirus / Vírus Reordenados / Rotavirus / Vacinas contra Rotavirus / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans / Infant / Male Idioma: En Revista: Vaccine Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Infecções por Rotavirus / Vírus Reordenados / Rotavirus / Vacinas contra Rotavirus / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans / Infant / Male Idioma: En Revista: Vaccine Ano de publicação: 2017 Tipo de documento: Article